Alterity Therapeutics
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WAAlterity Therapeutics Limited (ATH, formerly Prana Biotechnology Limited) is an Australian biotechnology company which focusses to commercialise research into Parkinsonian movement disorders, Alzheimer's disease, Huntington disease and other neurodegenerative disorders.
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 881st |  | Alterity Therapeutics | $3.9m |
| 1030th | | Ansarada Group | $721k |
| 1031st | | Cann Global | $701k |
| 1035th | | Respiri | $662k |
| 1036th | | Mediland Pharm | $662k |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 683rd | Respiri | 0% | 0% |
| 1257th | Mediland Pharm | -36% | -15% |
| 1389th | Alterity Therapeutics | -45% | -34% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEWS: Tagged in Investors encouraged not to sleep on medtechs | 08 Dec 2023 |
| NEW ROLE: Dianne Angus, Chief Operating Officer | 24 Nov 2020 |
| NEW ROLE: Kathryn Andrews, Chief Financial Officer | 24 Nov 2020 |
| NEW ROLE: David Stamler, Chief Medical Officer | 24 Nov 2020 |
| NEW ROLE: Brian D Meltzer, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Peter Marks, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Lawrence Gozlan, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Tristan Edwards, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Phillip Hains, Company Secretary | 03 Nov 2020 |
